Generics Top 5 Emerging Markets Industry Guide 2019-2028

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $995	234 Pages	MarketLine	December, 2024	MTLN19599836

Best Price Guarantee
Price	from $995
Length	234 Pages
Publisher	MarketLine
Published Date	December, 2024
SKU	MTLN19599836

Generics Top 5 Emerging Markets Industry Guide 2019-2028Summary

The Emerging 5 Generics industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume , and forecast to 2028). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights

These countries contributed $1,61,156.7 million to the global generics industry in 2023, with a compound annual growth rate (CAGR) of 12.1% between 2007 and 2011. The top 5 emerging countries are expected to reach a value of $2,33,053.5 million in 2028, with a CAGR of 7.7% over the 2023-28 period.
Within the generics industry, China is the leading country among the top 5 emerging nations, with market revenues of $1,21,016.7 million in 2023. This was followed by India and Brazil with a value of $22,824.0 and $9,214.4 million, respectively.
China is expected to lead the generics industry in the top five emerging nations, with a value of $1,77,196.9 million in 2028, followed by India and Brazil with expected values of $31,455.5 and $14,400.1 million, respectively.

Scope

Save time carrying out entry-level research by identifying the size, growth, and leading players in the emerging five generics market
Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the emerging five generics market
Leading company profiles reveal details of key generics market players’ emerging five operations and financial performance
Add weight to presentations and pitches by understanding the future growth prospects of the emerging five generics market with five year forecasts by both value and volume
Compares data from Brazil, China, India, Mexico and South Africa, alongside individual chapters on each country

Reasons to Buy

What was the size of the emerging five generics market by value in 2023?
What will be the size of the emerging five generics market in 2028?
What factors are affecting the strength of competition in the emerging five generics market?
How has the market performed over the last five years?
How large is the emerging five generics market in relation to its regional counterparts?

1 Introduction: 1.1. What is this report about?; 1.2. Who is the target reader?; 1.3. How to use this report; 1.4. Definitions
2 Top 5 Emerging Countries Generics: 2.1. Industry Outlook
3 Generics in South Africa: 3.1. Market Overview; 3.2. Market Data; 3.3. Market Segmentation; 3.4. Market outlook; 3.5. Five forces analysis
4 Macroeconomic Indicators: 4.1. Country data
5 Generics in Brazil: 5.1. Market Overview; 5.2. Market Data; 5.3. Market Segmentation; 5.4. Market outlook; 5.5. Five forces analysis
6 Macroeconomic Indicators: 6.1. Country data
7 Generics in China: 7.1. Market Overview; 7.2. Market Data; 7.3. Market Segmentation; 7.4. Market outlook; 7.5. Five forces analysis
8 Macroeconomic Indicators: 8.1. Country data
9 Generics in India: 9.1. Market Overview; 9.2. Market Data; 9.3. Market Segmentation; 9.4. Market outlook; 9.5. Five forces analysis
10 Macroeconomic Indicators: 10.1. Country data
11 Generics in Mexico: 11.1. Market Overview; 11.2. Market Data; 11.3. Market Segmentation; 11.4. Market outlook; 11.5. Five forces analysis
12 Macroeconomic Indicators: 12.1. Country data
13 Company Profiles: 13.1. Teva Pharmaceutical Industries Ltd; 13.2. Viatris Inc; 13.3. Sun Pharmaceutical Industries Ltd; 13.4. Novartis AG; 13.5. Sandoz Group AG; 13.6. Hikma Pharmaceuticals Plc; 13.7. Sanofi; 13.8. Les Laboratoires Servier SAS; 13.9. Stada Arzneimittel AG; 13.10. Bayer AG; 13.11. Lupin Ltd; 13.12. Aspen Pharmacare Holdings Ltd; 13.13. EMS SA; 13.14. Eurofarma Laboratorios SA; 13.15. Ache Laboratorios Farmaceuticos SA; 13.16. Apotex Inc; 13.17. Teva Canada Ltd; 13.18. Sandoz Canada Inc; 13.19. CSPC Pharmaceutical Group Ltd; 13.20. Sino Biopharmaceutical Ltd; 13.21. Hansoh Pharmaceutical Group Co Ltd; 13.22. Dr. Reddy's Laboratories Ltd; 13.23. Cipla Ltd; 13.24. Aurobindo Pharma Ltd; 13.25. PT Kalbe Farma Tbk; 13.26. PT Indofarma Tbk; 13.27. PT Sanbe Farma; 13.28. PT Soho Global Health Tbk; 13.29. Friulchem SpA; 13.30. DOC Generici SRL; 13.31. Recordati SpA; 13.32. Daiichi Sankyo Co Ltd; 13.33. Towa Pharmaceutical Co Ltd; 13.34. Sawai Group Holdings Co Ltd; 13.35. Toho Holdings Co Ltd; 13.36. Laboratorios Silanes SA de CV; 13.37. Pfizer Inc; 13.38. Biocad; 13.39. R-Pharm; 13.40. Pharmstandard; 13.41. AstraZeneca Plc; 13.42. Bluefish Pharmaceuticals AB; 13.43. Navamedic ASA; 13.44. Novartis International AG; 13.45. Beacons Pharmaceuticals Pte Ltd; 13.46. Abbott Laboratories SA; 13.47. Adcock Ingram Holdings Ltd; 13.48. Dongkook Pharmaceutical Co Ltd; 13.49. JW Holdings Corp; 13.50. Hanmi Pharmaceuticals Co Ltd; 13.51. Dong Wha Pharma Co Ltd; 13.52. Esteve Pharmaceuticals SA; 13.53. Abdi Ibrahim Ilac Sanayi ve Ticaret AS; 13.54. Deva Holding AS; 13.55. Sandoz Inc
14 Appendix: 14.1. Methodology; 14.2. About MarketLine
List of Tables: Table 1: Top 5 emerging countries generics industry, revenue ($m), 2019-28; Table 2: Top 5 emerging countries generics industry, revenue ($m), 2019-23; Table 3: Top 5 emerging countries generics industry forecast, revenue ($m), 2023-28; Table 4: South Africa generics market value: $ million, 2018-23; Table 5: South Africa generics market volume: % of total pharma volume, 2018-23; Table 6: South Africa generics market geography segmentation: $ million, 2023; Table 7: South Africa generics market value forecast: $ million, 2023-28; Table 8: South Africa generics market volume forecast: % of total pharma volume, 2023-28; Table 9: South Africa Size of Population (million), 2019-23; Table 10: South Africa real GDP (Constant 2010 Prices, $ billion), 2019-23; Table 11: South Africa GDP (Current Prices, $ Billion), 2019-23; Table 12: South Africa Inflation, 2019-23; Table 13: South Africa Consumer Price Index (Absolute), 2019-23; Table 14: South Africa exchange rate, 2018-23; Table 15: Brazil generics market value: $ million, 2018-23; Table 16: Brazil generics market volume: % of total pharma volume, 2018-23; Table 17: Brazil generics market geography segmentation: $ million, 2023; Table 18: Brazil generics market value forecast: $ million, 2023-28; Table 19: Brazil generics market volume forecast: % of total pharma volume, 2023-28; Table 20: Brazil Size of Population (million), 2019-23; Table 21: Brazil real GDP (Constant 2010 Prices, $ billion), 2019-23; Table 22: Brazil GDP (Current Prices, $ Billion), 2019-23; Table 23: Brazil Inflation, 2019-23; Table 24: Brazil Consumer Price Index (Absolute), 2019-23; Table 25: Brazil exchange rate, 2018-23; Table 26: China generics market value: $ million, 2018-23; Table 27: China generics market volume: % of total pharma volume, 2018-23; Table 28: China generics market geography segmentation: $ million, 2023; Table 29: China generics market value forecast: $ million, 2023-28; Table 30: China generics market volume forecast: % of total pharma volume, 2023-28; Table 31: China Size of Population (million), 2019-23; Table 32: China real GDP (Constant 2010 Prices, $ billion), 2019-23; Table 33: China GDP (Current Prices, $ Billion), 2019-23; Table 34: China Inflation, 2019-23; Table 35: China Consumer Price Index (Absolute), 2019-23; Table 36: China exchange rate, 2018-23; Table 37: India generics market value: $ million, 2018-23; Table 38: India generics market volume: % of total pharma volume, 2018-23; Table 39: India generics market geography segmentation: $ million, 2023; Table 40: India generics market value forecast: $ million, 2023-28; Table 41: India generics market volume forecast: % of total pharma volume, 2023-28; Table 42: India Size of Population (million), 2019-23; Table 43: India real GDP (Constant 2010 Prices, $ billion), 2019-23; Table 44: India GDP (Current Prices, $ Billion), 2019-23; Table 45: India Inflation, 2019-23; Table 46: India Consumer Price Index (Absolute), 2019-23; Table 47: India exchange rate, 2018-23; Table 48: Mexico generics market value: $ million, 2018-23; Table 49: Mexico generics market volume: % of total pharma volume, 2018-23; Table 50: Mexico generics market geography segmentation: $ million, 2023; Table 51: Mexico generics market value forecast: $ million, 2023-28; Table 52: Mexico generics market volume forecast: % of total pharma volume, 2023-28; Table 53: Mexico Size of Population (million), 2019-23; Table 54: Mexico real GDP (Constant 2010 Prices, $ billion), 2019-23; Table 55: Mexico GDP (Current Prices, $ Billion), 2019-23; Table 56: Mexico Inflation, 2019-23; Table 57: Mexico Consumer Price Index (Absolute), 2019-23; Table 58: Mexico exchange rate, 2018-23; Table 59: Teva Pharmaceutical Industries Ltd: key facts; Table 60: Teva Pharmaceutical Industries Ltd: Annual Financial Ratios; Table 61: Teva Pharmaceutical Industries Ltd: Key Employees; Table 62: Viatris Inc: key facts; Table 63: Viatris Inc: Annual Financial Ratios; Table 64: Viatris Inc: Key Employees; Table 65: Sun Pharmaceutical Industries Ltd: key facts; Table 66: Sun Pharmaceutical Industries Ltd: Annual Financial Ratios; Table 67: Sun Pharmaceutical Industries Ltd: Key Employees; Table 68: Novartis AG: key facts; Table 69: Novartis AG: Annual Financial Ratios; Table 70: Novartis AG: Key Employees; Table 71: Sandoz Group AG: key facts; Table 72: Sandoz Group AG: Key Employees; Table 73: Hikma Pharmaceuticals Plc: key facts; Table 74: Hikma Pharmaceuticals Plc: Annual Financial Ratios; Table 75: Hikma Pharmaceuticals Plc: Key Employees; Table 76: Sanofi: key facts; Table 77: Sanofi: Annual Financial Ratios; Table 78: Sanofi: Key Employees; Table 79: Les Laboratoires Servier SAS: key facts; Table 80: Les Laboratoires Servier SAS: Key Employees; Table 81: Stada Arzneimittel AG: key facts; Table 82: Stada Arzneimittel AG: Key Employees; Table 83: Bayer AG: key facts; Table 84: Bayer AG: Annual Financial Ratios; Table 85: Bayer AG: Key Employees; Table 86: Bayer AG: Key Employees Continued; Table 87: Bayer AG: Key Employees Continued; Table 88: Lupin Ltd: key facts; Table 89: Lupin Ltd: Annual Financial Ratios; Table 90: Lupin Ltd: Key Employees; Table 91: Aspen Pharmacare Holdings Ltd: key facts; Table 92: Aspen Pharmacare Holdings Ltd: Annual Financial Ratios; Table 93: Aspen Pharmacare Holdings Ltd: Key Employees; Table 94: EMS SA: key facts; Table 95: EMS SA: Key Employees; Table 96: Eurofarma Laboratorios SA: key facts; Table 97: Eurofarma Laboratorios SA: Key Employees; Table 98: Ache Laboratorios Farmaceuticos SA: key facts; Table 99: Ache Laboratorios Farmaceuticos SA: Key Employees